Amphastar Pharmaceuticals (AMPH) Change in Acquisitions & Divestments (2016 - 2026)

Amphastar Pharmaceuticals' Change in Acquisitions & Divestments history runs 9 years deep, the most recent figure standing at $15.5 million for Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 45.2% year-over-year to $15.5 million in Q1 2026; TTM through Mar 2026 was $77.5 million, a 27.44% decrease from a year earlier, with the FY2025 full-year figure at $90.3 million, down 28.35% from the prior year.
• Change in Acquisitions & Divestments eased to $15.5 million in Q1 2026 per AMPH's latest filing, from $16.4 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $65.8 million in Q2 2024 and bottomed at -$179000.0 in Q4 2023.
• The 5-year median for Change in Acquisitions & Divestments is $13.6 million (2023), against an average of $17.6 million.
• Across the five-year window, Change in Acquisitions & Divestments sank 101.43% in 2023 and soared 4281.01% in 2024, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $12.5 million in 2022, then tumbled by 101.43% to -$179000.0 in 2023, then surged by 4281.01% to $7.5 million in 2024, then jumped by 119.7% to $16.4 million in 2025, then retreated by 5.72% to $15.5 million in 2026.
• Per Business Quant, the three latest AMPH Change in Acquisitions & Divestments figures stand at $15.5 million (Q1 2026), $16.4 million (Q4 2025), and $22.5 million (Q3 2025).